Center for Proteomic Chemistry
Novartis Institutes for Biomedical Research
Dr. Lukas Leder is affiliated to Center for Proteomic Chemistry, Novartis Institutes for Biomedical Research. Dr. Lukas Leder is currently providing services as Professor. Dr. Lukas Leder has authored and co-authored multiple peer-reviewed scientific papers and presented works at many national and International conferences. Dr. Lukas Leder contributions have acclaimed recognition from honourable subject experts around the world. Dr. Lukas Leder is actively associated with different societies and academies. Dr. Lukas Leder academic career is decorated with several reputed awards and funding. Dr. Lukas Leder research interests include Center for Proteomic Chemistry.
Ribociclib (LEE011): Mechanism of Action and Clinical Impact of This Selective Cyclin-Dependent Kinase 4/6 Inhibitor in Various Solid Tumors.